Product Details
Mint-Sertraline
Sertraline HCl100 mg
Capsule
DIN/PIN/NPN
02402408
Manufacturer
Mint Pharmaceuticals Inc.
Formulary Listing Date
2013-06-27
Unit Price
0.3303
Amount MOH Pays
0.3303
Coverage Status
General Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
Sertraline HCl: Sertraline therapy should be discontinued for 2 weeks before starting irreversible monoamine oxidase inhibitors (MAOI). Similarly irreversible MAOI should be discontinued for 2 weeks before starting sertraline.
ATC Code
N06AB06
Interchangeable Products
DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
---|---|---|---|
01962779 | Zoloft | 2.1464 | 0.3303 |
02240481 | Teva-Sertraline | 0.3303 | 0.3303 |
02469642 | Sertraline | 0.3303 | 0.3303 |
02386097 | Sertraline | 0.3303 | 0.3303 |
02353547 | Sertraline | 0.3303 | 0.3303 |
02245161 | Sandoz Sertraline | 0.3303 | 0.3303 |
02374579 | Ran-Sertraline | 0.3303 | 0.3303 |
02244840 | PMS-Sertraline | 0.3303 | 0.3303 |
02488450 | NRA-Sertraline | 0.3303 | 0.3303 |
02402408 | Mint-Sertraline | 0.3303 | 0.3303 |
02399431 | Mar-Sertraline | 0.3303 | 0.3303 |
02357178 | Jamp-Sertraline | 0.3303 | 0.3303 |
02287412 | Co Sertraline | 0.3303 | 0.3303 |
02390922 | Auro-Sertraline | 0.3303 | 0.3303 |
02238282 | Apo-Sertraline | 0.3303 | 0.3303 |
02477904 | AG-Sertraline | 0.3303 | 0.3303 |
02530953 | M-Sertraline | 0.3303 | 0.3303 |